Cargando…

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies

Detalles Bibliográficos
Autores principales: Kleebayoon, Amnuay, Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028255/
https://www.ncbi.nlm.nih.gov/pubmed/37088613
http://dx.doi.org/10.1016/j.cllc.2023.03.010
_version_ 1784909907390103552
author Kleebayoon, Amnuay
Wiwanitkit, Viroj
author_facet Kleebayoon, Amnuay
Wiwanitkit, Viroj
author_sort Kleebayoon, Amnuay
collection PubMed
description
format Online
Article
Text
id pubmed-10028255
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100282552023-03-21 Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies Kleebayoon, Amnuay Wiwanitkit, Viroj Clin Lung Cancer Letter to the Editor Elsevier Inc. 2023-07 2023-03-21 /pmc/articles/PMC10028255/ /pubmed/37088613 http://dx.doi.org/10.1016/j.cllc.2023.03.010 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kleebayoon, Amnuay
Wiwanitkit, Viroj
Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title_full Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title_fullStr Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title_full_unstemmed Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title_short Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
title_sort correspondence on sars-cov-2 vaccine uptake among patients with thoracic malignancies
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028255/
https://www.ncbi.nlm.nih.gov/pubmed/37088613
http://dx.doi.org/10.1016/j.cllc.2023.03.010
work_keys_str_mv AT kleebayoonamnuay correspondenceonsarscov2vaccineuptakeamongpatientswiththoracicmalignancies
AT wiwanitkitviroj correspondenceonsarscov2vaccineuptakeamongpatientswiththoracicmalignancies